ARTICLE | Company News
Miravant, Guidant deal
July 12, 2004 7:00 AM UTC
GDT will provide funding for MRVT's preclinical cardiovascular programs involving its PhotoPoint photodynamic therapy. MRVT will receive a $3 million upfront investment, and GDT will invest up to an a...